Trademark Search in Canada

OXFORD BIOMEDICA

View On IC.GC.CA

REGISTERED

on 11 Jun 2013

Last Applicant/ Owned by

OXFORD BIOMEDICA PLC

Medawar CentreRobert Robinson AvenueThe Oxford Science ParkOxford OX4 4GA

Serial Number

1432089 filed on 18^th Mar 2009

Registration Number

TMA853020 registered on 11^th Jun 2013

Registration expiry Date

11^th Jun 2028

Correspondent Address

BENNETT JONES LLP

1400 Stantec Tower10220 103 Avenue NWEdmonton

ALBERTA

T5J0K4

OXFORD BIOMEDICA

Trademark usage description

chemical products for use in industry and science, namely, enzymes for scientific and research purposes; chemical products for in-vitro use in laborat Read More

Classification Information

Class [001]
Chemical products for use in industry and science, namely, enzymes for scientific and research purposes; chemical products for in-vitro use in laboratories and for analysis, namely, for genetic engineering use; microorganisms, viruses, cell cultures, plasmids and cultures of micro-organisms, nucleic acid sequences, cloning vehicles, chemical products for use in biotechnology, research and development, namely, monoclonal antibodies for in vitro scientific or research use, chemicals for use in the purification of proteins for in vitro use, diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, antibody reagents used for the detection of antigens in cell and tissue analysis for immunology, research and development, and recombinant nucleic acids for in-vivo use.

Classification kind code

Class [005]
Therapeutic and prophylactic products, namely, gene delivery pharmaceuticals, small molecules, vaccines, biologics, enzymes and enzyme preparations, all for medical purposes; pharmaceuticals for the delivery of genes to cells, all for medical purposes in gene therapy; viral, retroviral and non-viral vectors, all for medical purposes in gene therapy; viral, retroviral and non-viral vector manufacturing preparations for laboratory and scientific research purposes for use in in vivo gene therapy; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious diseases, namely, viral and bacterial infections, HIV and AIDS related infections and bodily conditions associated with impaired immunosystems, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neurone disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the auto-immune system and inflammatory diseases, namely, lupus erythematosus, coeliac disease, Crohns disease, multiple sclerosis, myasthenia gravis, psoriatic arthritis and rheumatoid arthritis, single gene disorders, namely, familial hypercholesterolemia, polycystic kidney disease, Huntington's disease, hereditary spherocytosis, marfan syndrome, sickle cell anaemia, cystic fibrosis, Tay-Sachs disease, galactosemia, haemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation, Stargardt's disease and diseases of the eye, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; Pharmaceuticals and biochemicals for contraceptive purposes for the prevention of pregnancy.

Classification kind code

Class [010]
Instruments and apparatus for the administration of pharmaceutical, gene therapy and/or vaccine preparations and substances, namely, pre-filled vials, in-dwelling catheters and micropumps, syringes and injectors, all for the administration of gene therapy products; syringes and injectors for medical purposes.

Classification kind code

Class [042]
Scientific, pharmaceutical and medical research services and development services, all in relation to gene therapy; genetic engineering services, biotechnology services, advisory services relating to gene therapy products and clinical trials, conducting clinical trials.

Classification kind code

Class [044]
Medical services in relation to gene therapy; advisory services in respect of vaccination regimes; advisory services relating to the treatment, relief and/or prevention of cancer, infectious diseases, namely, viral and bacterial infections, HIV and AIDS related infections and bodily conditions associated with impaired immunosystems, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, namely, ataxia, dementia, epilepsy, Alzheimer's, cerebral palsy, stroke, motor neurone disease, Parkinson's disease, spinal injury, avulsion injury and peripheral neuropathies, cardiovascular disease, diseases affecting the auto-immune system and inflammatory diseases, namely, lupus erythematosus, coeliac disease, Crohns disease, multiple sclerosis, myasthenia gravis, psoriatic arthritis and rheumatoid arthritis, single gene disorders, namely, familial hypercholesterolemia, polycystic kidney disease, Huntington's disease, hereditary spherocytosis, marfan syndrome, sickle cell anaemia, cystic fibrosis, Tay-Sachs disease, galactosemia, haemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation, Stargardt's disease and diseases of the eye, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders, and pharmaceuticals and biochemicals for contraceptive purposes for the prevention of pregnancy, in humans and animals.

Classification kind code

Mark Details

Serial Number

1432089

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 15 on 6^th Mar 2012	Correspondence Created
Submitted for opposition 12 on 14^th Jul 2011	Extension of Time
Submitted for opposition 12 on 17^th Feb 2011	Extension of Time
Submitted for opposition 12 on 22^nd Jul 2010	Extension of Time
Submitted for opposition 20 on 14^th Jan 2010	Examiner's First Report
Submitted for opposition 22 on 25^th Nov 2009	Search Recorded
Submitted for opposition 130 on 7^th Apr 2009	Note to file
Submitted for opposition 31 on 27^th Mar 2009	Formalized
Submitted for opposition 1 on 24^th Mar 2009	Created
Submitted for opposition 30 on 18^th Mar 2009	Filed

OXFORD BIOMEDICA

Classification Information

Classification kind code

Classification kind code

Classification kind code

Class [042]Scientific, pharmaceutical and medical research services and development services, all in relation to gene therapy; genetic engineering services, biotechnology services, advisory services relating to gene therapy products and clinical trials, conducting clinical trials.

Classification kind code

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [042]
Scientific, pharmaceutical and medical research services and development services, all in relation to gene therapy; genetic engineering services, biotechnology services, advisory services relating to gene therapy products and clinical trials, conducting clinical trials.